证券记录 · 已归档季度
IART
Integra LifeSciences Holdings Corporation · Healthcare · Medical - Devices
10被追踪持有人
-2Δ持有人
8.70M持有股份
$191.38M报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -16.7% ·
股份流向 -1.6% ·
净新建仓位 -20.0%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +6 | 47.61M | $854.64M | +10 | −4 |
| Q1 2026 | 80 | -2 | 47.10M | $443.79M | +5 | −7 |
| Q4 2025 | 82 | +1 | 50.51M | $627.34M | +2 | −1 |
| Q3 2025 | 15 | -2 | 31.34M | $449.05M | — | −2 |
| Q2 2025 | 14 | +1 | 26.22M | $321.73M | +1 | — |
| Q1 2025 | 10 | -2 | 8.70M | $191.38M | — | −2 |
| Q4 2024 | 12 | -1 | 8.85M | $200.63M | — | −1 |
| Q3 2024 | 12 | 0 | 6.56M | $119.23M | +1 | −1 |
| Q2 2024 | 12 | — | 9.27M | $269.75M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.77M | +10.4% | $60.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.77M | +10.4% | $60.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.77M | +10.4% | $60.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.77M | +10.4% | $60.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 2.75M | -3.7% | $60.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (被动) | 2.75M | -3.7% | $60.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 1.66M | +5.5% | $36.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.66M | +5.5% | $36.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 418.98K | +1809.0% | $9.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 418.98K | +1809.0% | $9.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 386.00K | -23.0% | $8.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 341.63K | -53.4% | $7.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 217.57K | +153.8% | $4.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 62.76K | -1.6% | $1.38M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 62.76K | -1.6% | $1.38M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 62.76K | -1.6% | $1.38M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 62.76K | -1.6% | $1.38M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 62.76K | -1.6% | $1.38M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 51.65K | +9.7% | $1.14M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 47.20K | 0.0% | $1.04M | 0.0% | Held | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $8.97M | 曾为 0.0% |
| Arrowstreet Capital | $311,986 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 200 持有人, 74.41M 股份, $694.31M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据